-12.6%
NVDA vs EMR
+29.1%
-41.7%
-31.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | 0.0% | -2.0% | -2.0% |
| 7D | -12.7% | +2.8% | -15.6% | -13.7% |
| 30D | -26.4% | +3.7% | -30.1% | -27.2% |
| 3M | -27.6% | +2.0% | -29.7% | -28.1% |
| 6M | -27.7% | +22.1% | -49.8% | -32.3% |
| YTD | -12.5% | +27.2% | -39.7% | -20.2% |
| 1Y | -12.6% | +32.0% | -44.7% | -20.9% |
| All | -12.6% | +29.1% | -41.7% | -20.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling